Company / Current Assets
Perspective Therapeutics, Inc. Current Assets History
FY2013-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$53.2M
FY2022
5-year range
$5.4M / $67.3M
FY2018-FY2022
Trend
-20.9%
vs FY2021
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Assets has fluctuated over the past 10 years, ranging from $4M in FY2013 to $67M in FY2021.
Based on SEC 10-K filings.
$53M in FY2022 with a 5-year CAGR of +38.9%.
Improved from $6M to $53M over the past 2 years.
Current Assets over time
Growth rates
- 3-Year CAGR
- +93.8%
- 5-Year CAGR
- +38.9%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +38.9%, indicating consistent growth.
- In FY2022, current assets decreased 20.9% year-over-year.
- Peak current assets was recorded in FY2021.
- Lowest current assets in the period was in FY2013.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 5.43 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2022 | $53.2M | -20.9% |
| FY2021 | $67.3M | +1122.1% |
| FY2020 | $5.5M | -24.7% |
| FY2019 | $7.3M | +34.3% |
| FY2018 | $5.4M | -47.1% |
| FY2017 | $10.3M | -24.5% |
| FY2016 | $13.6M | -16.5% |
| FY2015 | $16.3M | -15.0% |
| FY2014 | $19.2M | +332.4% |
| FY2013 | $4.4M | - |
As of FY2022 · SEC 10-K · Updated Jun 24, 2026